首都医科大学学报 ›› 2008, Vol. 29 ›› Issue (6): 758-761.

• 临床研究 • 上一篇    下一篇

慢性肾功能不全患者应用碘克沙醇临床报告

高亢, 杨明, 王青, 韩凌, 尹朝霞, 赵燕, 陈欣, 陈立伟, 岑强, 胡文泽, 孙一光   

  1. 首都医科大学附属复兴医院心脏中心
  • 收稿日期:2008-04-09 修回日期:1900-01-01 出版日期:2008-12-24 发布日期:2008-12-24

Application of Lodixanol on Patients with Chronic Renal Failure

Gao Kang, Yang Ming, Wang Qing, Han Ling, Yin Zhaoxia, Zhao Yan, Chen Xin, Chen Liwei, Cen Qiang, Hu Wenze, Sun Yiguang   

  1. Department of Cardiology, Beijing Fuxing Hospital, Capital Medical University
  • Received:2008-04-09 Revised:1900-01-01 Online:2008-12-24 Published:2008-12-24

摘要: 目的 探讨碘克沙醇对重度肾功能不全患者的影响.方法 回顾性分析住院行冠状动脉造影及介入治疗126例患者的资料,根据造影剂的选择将受试者分为等渗造影剂-碘克沙醇组(A组),72例;低渗造影剂.碘海醇组(B组),54例.比较2组患者的临床特点、造影前后血清肌酐(Scr)和肌酐清除率(Ccr)的变化、造影剂肾病(CIN)的发生率以及近期预后.结果 慢性肾功能不全患者发生CIN的危险因素在2组问差异尤统计学意义;2种造影剂均可能引起Scr的增高及Ccr的下降,导致CIN的发牛,但碘克沙醇组CIN发病率明显低于碘海醇组(4.2%vs29.6%,P<0.05);6例受试者发生不良反应,其中碘海醇组5例,碘克沙醇组1例.结论 与低渗性造影剂相比,等渗性造影剂可以降低Scr水平及RCIN的发病率,减少不良事件的发生,适用于慢性肾功能不全患者或合并糖尿病患者.

关键词: 慢性肾功能不全患者, 碘克沙醇, 造影剂肾病, 不良事件

Abstract: Objective To discuss the effects of lodixanol on patients with moderate to severe renal failure.Methods One hundred and twenty-six patients who had undergone coronary angiography and intervention were retrospectively analyzed.These 126 cases were divided into group A(72 cases,using lodixanol) and group B(54 cases,using iohexol).Between group A and B,the clinical features,serum creatinine(Scr),creatinine clearance rates(Ccr),and mobidity rates and prognosis of radiocontrast induced nephropathy(CIN) were compared.Results There was no difference in pre-procedure risk factors of CINbetween group A and B.In both groups there were Scr increasing and Ccr decreasing which caused CIN.However,the CIN rates were lower in group Athan in group B(4.2% vs 29.6%,P<0.05).There were 6 cases of adverse effects,5 of them were in group B.Conclusion Comparing with hypotonic contrast agents,the isotonic contrast agents could lower Scr baseline level and CINoccurrence rates,at the same time adverse effects can be reduced especially in patients with chronic renal failure or diabetes.

Key words: patients with chronic renal failure, lodixanol, contrast-induced nephropathy, adverse effects

中图分类号: